– Reuters
Citron Research Reports On Apellis Pharmaceuticals (APLS); Says “Happy Days Are OVER For Apellis, As The Experts Give A Thumbs Down To Syfovre. Citron Expects FDA Warning Letter.”
https://citronresearch.com/wp-content/uploads/2023/11/Citron-Reports-on-Apellis-Pharmaceuticals.pdfCitron Research was committed to ensuring that its return to short selling was marked by a report that would not only